Basics Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure. IPO Date: March 1, 2007 Sector: Healthcare Industry: Biotech Market Cap: $256.02M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.93% Avg Daily Range (30 D): $0.22 | 3.33% Avg Daily Range (90 D): $0.24 | 3.41% Institutional Daily Volume Avg Daily Volume: .66M Avg Daily Volume (30 D): 1.3M Avg Daily Volume (90 D): 1.61M Trade Size Avg Trade Size (Sh.): 181 Avg Trade Size (Sh.) (30 D): 137 Avg Trade Size (Sh.) (90 D): 135 Institutional Trades Total Inst.Trades: 324 Avg Inst. Trade: $1.3M Avg Inst. Trade (30 D): $.72M Avg Inst. Trade (90 D): $.99M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.47M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $1.09M Avg Closing Volume: 130.24K     News Sep 25, 2025 @ 3:16 PM Why Capricor Therapeutics Stock Is Surging Today Source: Alex Perry Sep 15, 2025 @ 7:58 PM Shareholders of Capricor Therapeutics, Inc. Should... Source: The Gross Law Firm Sep 14, 2025 @ 8:00 PM CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc Sep 14, 2025 @ 1:44 PM CAPR IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR C... Source: Rosen Law Firm Sep 14, 2025 @ 1:27 PM CAPRICOR DEADLINE ALERT: Bragar Eagel & Squire, P.... Source: Bragar Eagel & Squire, P.C. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.75 $-.54 $-.57 Diluted EPS $-1.75 $-.54 $-.57 Revenue $ 11.13M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -81.99M $ -24.57M $ -25.91M Operating Income / Loss $ -86.68M $ -26.28M $ -27.72M Cost of Revenue $ $ $ Net Cash Flow $ -48.87M $ -3.73M $ -5.55M PE Ratio     Splits Jun 05, 2019:   1:10 Nov 21, 2013:   1:50 Feb 09, 2007:   1:10 Apr 05, 2005:   1:20